Dysglycemia in critically ill children

Halla Kamińska1, Paweł Wieczorek2, Eliza Skała-Zamorowska1

  • 1Department of Children's Diabetology, School of Medicine in Katowice, Medical University of Silesia in Katowice, Poland.

Insights

Stress hyperglycemia in critically ill children is a major challenge with no clear treatment guidelines. This review explores its causes, risks of low blood sugar, and blood sugar fluctuations.

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Metabolic Disorders

Background:

  • Stress hyperglycemia is a common, yet poorly understood, complication in critically ill children.
  • Current management strategies for hyperglycemia in this population lack consensus and professional guidelines.
  • Glycemic variability and hypoglycemia pose significant risks that require careful consideration.

Purpose of the Study:

  • To review the current understanding of the pathogenesis of stress hyperglycemia in critically ill children.
  • To highlight the clinical significance and risks associated with hypoglycemic episodes and glycemic variability.
  • To inform future research and potential guideline development for hyperglycemia management.

Main Methods:

  • Literature review of recent research on stress hyperglycemia in pediatric critical care.
  • Analysis of studies investigating the mechanisms behind stress-induced high blood sugar.
  • Examination of data on the impact of blood glucose fluctuations and low blood sugar events.

Main Results:

  • Stress hyperglycemia is multifactorial, involving hormonal and inflammatory pathways.
  • Hypoglycemic episodes and high glycemic variability are associated with increased morbidity and mortality.
  • Existing literature provides insights into pathogenesis but lacks definitive treatment protocols.

Conclusions:

  • Further research is needed to elucidate the precise mechanisms of stress hyperglycemia in children.
  • Understanding glycemic variability and hypoglycemia is crucial for optimizing patient outcomes.
  • Development of evidence-based guidelines for managing hyperglycemia in critically ill children is essential.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
991
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K